Genus plc#Operations
{{Short description|British biotechnology company}}
{{Use dmy dates|date=April 2022}}
{{Infobox company
| name = Genus plc
| logo = Genus logo.svg
| logo_size = 170px
| type = Public
| traded_as = {{ubl|{{lse|GNS}}|FTSE 250 component}}
| foundation = 1933
| location = Basingstoke, Hampshire, UK
| key_people = Iain Ferguson, Chairman{{cite web|url=https://www.genusplc.com/about-us/our-leadership/our-team|publisher=Genus plc|title=About Us - Our Team|access-date=2 August 2023}}
Jorgen Kokke, CEO
| industry = Biotechnology
| products =
| revenue = {{decrease}} £668.8 million (2024){{cite web|url=https://www.genusplc.com/media/2187/genus-plc-ar24.pdf|title=Annual Report 2024|publisher=Genus plc|access-date=10 February 2025}}
| operating_income = {{decrease}} £6.4 million (2024)
| net_income = {{decrease}} £2.4 million (2024)
| num_employees =
| parent =
| subsid =
| homepage = {{URL|http://www.genusplc.com}}
| caption =
| footnotes =
}}
Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
History
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[http://www.bseinquiry.gov.uk/report/volume12/chapte32.htm The BSE Inquiry] {{webarchive|url=https://web.archive.org/web/20081010165925/http://www.bseinquiry.gov.uk/report/volume12/chapte32.htm |date=2008-10-10 }} In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.{{cite web|url=https://www.bizjournals.com/milwaukee/stories/1999/08/02/daily5.html|title=Genus agrees to acquire ABS Global|publisher=Milwaukee Business Journal|date=3 August 1999|access-date=1 March 2020}} In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.{{cite web|url=http://www.thepigsite.com/swinenews/10541/genus-completes-acquisition-of-sygen|title=Genus Completes Acquisition Of Sygen|work=The Pig Site|access-date=28 March 2015|archive-url=https://web.archive.org/web/20120209234541/http://www.thepigsite.com/swinenews/10541/genus-completes-acquisition-of-sygen|archive-date=9 February 2012|url-status=dead}}
Operations
The company has three divisions:{{cite web|url=https://www.marketwatch.com/investing/stock/gns/profile?countrycode=uk|title=Genus|publisher=Market Watch|access-date=25 March 2018}}
- ABS - products for cattle
- PIC - products for pigs
- Genus R&D - management of the research and development pipeline for cattle, pigs and other species.
PIC's pedigree herds sire an estimated 30% of commercially reared pigs.{{cite web | last=Devlin | first=Hannah | title=Scientists genetically engineer pigs immune to costly disease | website=The Guardian | date=20 June 2018 | url=http://www.theguardian.com/science/2018/jun/20/scientists-genetically-engineer-pigs-immune-to-costly-disease | access-date=11 December 2021}}
References
{{reflist|30em}}
External links
- [http://www.genusplc.com Official site]
{{Agriculture in the United Kingdom}}
{{Pharmaceutical and biotechnology industry in the United Kingdom}}
{{FTSE 250 Index constituents}}
{{Authority control}}
Category:Biotechnology companies established in 1933
Category:Biotechnology companies of the United Kingdom
Category:Companies based in Basingstoke
Category:Companies listed on the London Stock Exchange